Signal transducers and activators of transcription protein 1 (STAT1) is activated in macrophages by Zymosan through Dectin-1
Author affiliations
DOI:
https://doi.org/10.15625/0866-7160/v32n4.726Keywords:
STAT1, Zymosan, Dectin-1Abstract
Zymosan, an insoluble preparation of yeast cell, has been shown to recognized by Dectin-1, a phagocytic receptor expressed on macrophages and dendritic cells, which collaborates with toll-like receptor (TLR) 2 and TLR6 enhancing the immune responses triggered by the recognition of zymosan by each receptor. Although zymosan has been reported as a target molecule for TLR signaling, the role(s) of signal transducers and activators of transcription protein (STAT) 1 on the innate immune responses induced by zymosan remain elusive. In the present study, we investigate the role of STAT1 on the zymosan-induced production of proinflammatory cytokines by murine bone marrow-derived macrophages (BMDMs). Zymosan-induced proinflammatory cytokine production was dependent on the activation of STAT1, because the mRNA of cytokines and chemokines were totally abrogated in STAT1-deficient BMDMs. In addition, zymosan actively induced the activation of STAT1 through both Tyr-701 and Ser-727 phosphorylation by BMDMs.Furthermore, Dectin-1 was required for zymosan-induced STAT1 activation in macrophages. Taken together, these results indicate that STAT1 activation plays an essential role in the induction of innate immune responses to zymosan-induced innate immune responses via Dectin-1.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Academia Journal of Biology (AJB) is an open-access and peer-reviewed journal. The articles published in the AJB are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits for immediate free access to the articles to read, download, copy, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited (with a link to the formal publication through the relevant DOI), and without subscription charges or registration barriers. The full details of the CC BY-NC-ND 4.0 License are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.